Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXZA4I
|
||||
Drug Name |
4-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-pentanoyl-piperazine-2-carboxylic acid (pyridin-3-ylmethyl)-amide
|
||||
Synonyms |
CHEMBL202272
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H33BrClN5O2
|
||||
Canonical SMILES |
CCCCC(=O)N1CCN(CC1C(=O)NCc2cccnc2)C3c4ccc(Cl)cc4CCc5cc(Br)cnc35
|
||||
InChI |
InChI=1S/C30H33BrClN5O2/c1-2-3-6-27(38)37-13-12-36(19-26(37)30(39)35-17-20-5-4-11-33-16-20)29-25-10-9-24(32)15-21(25)7-8-22-14-23(31)18-34-28(22)29/h4-5,9-11,14-16,18,26,29H,2-3,6-8,12-13,17,19H2,1H3,(H,35,39)
|
||||
InChIKey |
HUOQFTKEEWWMLS-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.